PCVX

Vaxcyte Inc

NASDAQ: PCVX · HEALTHCARE · BIOTECHNOLOGY

$53.99

-2.87% today

Updated 2026-06-05

Market cap

$6.85B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-6.89

Dividend yield

—

52W range

$29 – $65

Volume

1.4M

Market cap

$6.85B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-6.89

Dividend yield

—

52W range

$29 – $65

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

3.2

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$109.00

+101.89%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Altman Z 3.21 — safe zone

+ Debt/equity 0.04x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-295.42M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-223.49M	$-402.27M	$-463.93M	$-766.63M	$-320.62M
EPS	—	—	—	—	$-6.89
Free cash flow	$-176.44M	$-364.67M	$-475.05M	$-669.29M	$-295.42M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-06-01	WASSIL, JIM	Sale	1,949	$49.40
2026-06-01	WASSIL, JIM	Sale	301	$50.26
2026-05-01	WASSIL, JIM	Sale	2,250	$56.83

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PCVX	$6.85B	30	4.3	3.0	5.0	8.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Vaxcyte Inc trades at $53.99. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 3.21, it sits in the safe zone.

Frequently asked questions

What is Vaxcyte Inc's stock price?

Vaxcyte Inc (PCVX) trades at $53.99.

Is Vaxcyte Inc overvalued?

Vaxcyte Inc carries a Smart Value Score of 30/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Vaxcyte Inc (PCVX)?

The 12-month analyst consensus target is $109.00, about 101.9% above the current $53.99. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Vaxcyte Inc's Altman Z-Score is 3.21, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-31.59%

Beta1.24

50D MA$54.48

200D MA$48.67

Shares out0.14B

Float0.13B

Short ratio—

Avg volume1.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PCVX vs LLY →PCVX vs JNJ →PCVX vs ABBV →Stock screener →